These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 38493719

  • 21. Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition.
    Zhang LM, Zhang Y, Fei C, Zhang J, Wang L, Yi ZW, Gao G.
    Biochem Biophys Res Commun; 2019 Jan 08; 508(2):660-666. PubMed ID: 30527805
    [Abstract] [Full Text] [Related]

  • 22. Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis.
    Chen XY, Dong YC, Yu YY, Jiang M, Bu WJ, Li P, Sun ZJ, Dong DL.
    Br J Pharmacol; 2023 Dec 08; 180(23):3008-3023. PubMed ID: 37428102
    [Abstract] [Full Text] [Related]

  • 23. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L, Jiang D, Geng J, Dong R, Dai H.
    Exp Physiol; 2019 Dec 08; 104(12):1942-1951. PubMed ID: 31535412
    [Abstract] [Full Text] [Related]

  • 24. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway.
    Sun Q, Hu J, Yu P, Zhu Z, Yu R, Ge C, Li C, Wu G, Lin B, Liu G, Liu M, Bian H, Xu H, Jia S.
    Exp Lung Res; 2019 Dec 08; 45(5-6):123-134. PubMed ID: 31210057
    [Abstract] [Full Text] [Related]

  • 25. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
    Han YY, Gu X, Yang CY, Ji HM, Lan YJ, Bi YQ, Si R, Qu J, Cheng MH, Gao J.
    J Cell Physiol; 2021 Nov 08; 236(11):7734-7744. PubMed ID: 34061990
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW, Jia YL, Ge LT, Jiang B, Jiang JX, Shen J, Jin YC, Guan Y, Sun Y, Xie QM.
    Toxicology; 2017 Aug 15; 389():31-41. PubMed ID: 28694203
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evening primrose and its compounds of 1-Oxohederagenin and remangilone C ameliorate bleomycin-induced pulmonary fibrosis by regulating β-catenin signaling.
    Zhang Q, Zeng M, Zhang B, Wang R, Fan R, Hu Y, Liu J, Zheng X, Feng W.
    Phytomedicine; 2024 Oct 15; 133():155933. PubMed ID: 39121537
    [Abstract] [Full Text] [Related]

  • 31. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J, Feng M, Sun R, Li Z, Hu L, Peng G, Xu X, Wang W, Cui F, Yue W, He J, Liu J.
    Toxicol Lett; 2020 Mar 15; 321():103-113. PubMed ID: 31706003
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T.
    J Surg Res; 2015 Jul 15; 197(1):167-75. PubMed ID: 25911951
    [Abstract] [Full Text] [Related]

  • 34. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T, Velavan B, Sudhandiran G.
    Basic Clin Pharmacol Toxicol; 2018 Aug 15; 123(2):122-129. PubMed ID: 29394529
    [Abstract] [Full Text] [Related]

  • 35. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
    Tan ZX, Chen YH, Xu S, Qin HY, Zhang C, Zhao H, Xu DX.
    Toxicol Lett; 2016 Jan 05; 240(1):161-71. PubMed ID: 26520185
    [Abstract] [Full Text] [Related]

  • 36. The role of quercetin in ameliorating bleomycin-induced pulmonary fibrosis: insights into autophagy and the SIRT1/AMPK signaling pathway.
    Li Z, Jiao Y, Wu Z, Liu H, Li Y, Cai Y, Wei W, Cao F.
    Mol Biol Rep; 2024 Jul 13; 51(1):795. PubMed ID: 39001907
    [Abstract] [Full Text] [Related]

  • 37. Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway.
    Bo C, Liu F, Zhang Z, Du Z, Xiu H, Zhang Z, Li M, Zhang C, Jia Q.
    BMC Pulm Med; 2024 May 08; 24(1):224. PubMed ID: 38720270
    [Abstract] [Full Text] [Related]

  • 38. Histone deacetylase 3 deletion in alveolar type 2 epithelial cells prevents bleomycin-induced pulmonary fibrosis.
    Xiong R, Geng B, Jiang W, Hu Y, Hu Z, Hao B, Li N, Geng Q.
    Clin Epigenetics; 2023 Nov 11; 15(1):182. PubMed ID: 37951958
    [Abstract] [Full Text] [Related]

  • 39. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice.
    Washimkar KR, Tomar MS, Kulkarni C, Verma S, Shrivastava A, Chattopadhyay N, Mugale MN.
    Life Sci; 2023 Oct 15; 331():122064. PubMed ID: 37657527
    [Abstract] [Full Text] [Related]

  • 40. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
    Wu YX, Zhang YR, Jiang FJ, He S, Zhang YL, Chen D, Tong Y, Nie YJ, Pang QF.
    Inflamm Res; 2023 Jun 15; 72(6):1133-1145. PubMed ID: 37169970
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.